Immunosuppression preserves renal autoregulatory function and microvascular P2X1 receptor reactivity in ANG II-hypertensive rats

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 6, 2013, Pages

  Guan, Zhengrong ^a   Giddens, Matthew I ^a   Osmond, David A ^a   Cook, Anthony K ^a   Hobbs, Janet L ^a   Zhang, Shali ^a   Yamamoto, Tatsuo ^b   Pollock, Jennifer S ^a   Pollock, David M ^a   Inscho, Edward W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Numazu City Hospital   (Japan)

Author keywords

Afferent arteriole; Autoregulation; Inflammation; Lymphocytes; Mycophenolate mofetil; Renal blood flow

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PURINERGIC P2X1 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; 5' ADENYLYL (BETA,GAMMA METHYLENE)DIPHOSPHONATE; 5'-ADENYLYL (BETA,GAMMA-METHYLENE)DIPHOSPHONATE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; TGFB1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PERFUSION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; NEPHRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RENOVASCULAR HYPERTENSION; SIGNAL TRANSDUCTION; TREATMENT DURATION; VASOCONSTRICTION; ALBUMINURIA; ANIMAL; ARTERIOLE; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HOMEOSTASIS; HYPERTENSION; IMMUNOLOGY; KIDNEY CIRCULATION; LYMPHOCYTE; METABOLISM; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ALBUMINURIA; ANGIOTENSIN II; ANIMALS; ARTERIOLES; HOMEOSTASIS; HYPERTENSION; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MACROPHAGES; MALE; MYCOPHENOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X1; RENAL CIRCULATION; TRANSFORMING GROWTH FACTOR BETA1;

MLCS; MLOWN;

EID: 84877930434     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00286.2012     Document Type: Article

References (34)

1. Bailey MA, Shirley DG. Effects of extracellular nucleotides on renal tubular solute transport. Purinergic Signal 5: 473-480, 2009.
2. Bidani AK, Griffin KA, Williamson G, Wang X, Loutzenhiser R. Protective importance of the myogenic response in the renal circulation. Hypertension 54: 393-398, 2009.
3. Boesen EI, Williams DL, Pollock JS, Pollock DM. Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats. Clin Exp Pharmacol Physiol 37: 1016-1022, 2010.
4. Chan CM, Unwin RJ, Bardini M, Oglesby IB, Ford AP, Townsend-Nicholson A, Burnstock G. Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am J Physiol Renal Physiol 274: F799-F804, 1998.
5. Crowley SD, Frey CW, Gould SK, Griffiths R, Ruiz P, Burchette JL, Howell DN, Makhanova N, Yan M, Kim HS, Tharaux PL, Coffman TM. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am J Physiol Renal Physiol 295: F515-F524, 2008.
6. De Miguel C, Das S, Lund H, Mattson DL. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 298: R1136-R1142, 2010.
7. Franco M, Martinez F, Rodriguez-Iturbe B, Johnson RJ, Santamaria J, Montoya A, Nepomuceno T, Bautista R, Tapia E, Herrera-Acosta J. Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension. Am J Physiol Renal Physiol 291: F1281-F1287, 2006.
8. Gever JR, Cockayne DA, Dillon MP, Burnstock G, Ford AP. Pharmacology of P2X channels. Pflügers Arch 452: 513-537, 2006.
9. Graciano ML, Nishiyama A, Jackson K, Seth DM, Ortiz RM, Prieto-Carrasquero MC, Kobori H, Navar LG. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Renal Physiol 294: F161-F169, 2008.
10. Guan Z, Fuller BS, Yamamoto T, Cook AK, Pollock JS, Inscho EW. Pentosan polysulfate treatment preserves renal autoregulation in ANG II-Infused hypertensive rats via normalization of P2X1 receptor activation. Am J Physiol Renal Physiol 298: F1276-F1284, 2010.
11. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460, 2007.
12. Harhun MI, Povstyan OV, Gordienko DV. Purinoreceptor-mediated current in myocytes from renal resistance arteries. Br J Pharmacol 160: 987-997, 2010.
13. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, hypertension. Hypertension 57: 132-140, 2011.
14. Inscho EW. ATP, P2 receptors and the renal microcirculation. Purinergic Signal 5: 447-460, 2009.
15. Inscho EW, Cook AK, Clarke A, Zhang S, Guan Z. P2X1 receptor-mediated vasoconstriction of afferent arterioles in ANG II-infused hypertensive rats fed a high salt diet. Hypertension 57: 780-787, 2011.
16. Inscho EW, Cook AK, Murzynowski JB, Imig JD. Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activation. J Hypertens 22: 811-818, 2004.
17. Inscho EW, Imig JD, Deichmann PC, Cook AK. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats. J Am Soc Nephrol 10, Suppl 11: S178-S183, 1999.
18. Komlosi P, Bell PD, Zhang ZR. Tubuloglomerular feedback mechanisms in nephron segments beyond the macula densa. Curr Opin Nephrol Hypertens 18: 57-62, 2009.
19. Kopkan L, Castillo A, Navar LG, Majid DS. Enhanced superoxide generation modulates renal function in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol 290: F80-F86, 2006.
20. Krotz F, Keller M, Derflinger S, Schmid H, Gloe T, Bassermann F, Duyster J, Cohen CD, Schuhmann C, Klauss V, Pohl U, Stempfle HU, Sohn HY. Mycophenolate acid inhibits endothelial NAD(P)H oxidase activity and superoxide formation by a Rac1-dependent mechanism. Hypertension 49: 201-208, 2007.
21. Lewis CJ, Evans RJ. P2X receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J Vasc Res 38: 332-340, 2001.
22. Mattar AL, Machado FG, Fujihara CK, Malheiros DM, Zatz R. Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition. Clinics (Sao Paulo) 62: 749-756, 2007.
23. Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F, Fiebeler A, Ju X, Finckenberg P, Theuer J, Viedt C, Kreuzer J, Heidecke H, Haller H, Zenke M, Luft FC. Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 161: 1679-1693, 2002.
24. Nelson PH, Eugui E, Wang CC, Allison AC. Synthesis and immunosuppressive activity of some side-chain variants of mycophenolic acid. J Med Chem 33: 833-838, 1990.
25. Nishiyama A, Rahman M, Inscho EW. Role of interstitial ATP and adenosine in the regulation of renal hemodynamics and microvascular function. Hypertens Res 27: 791-804, 2004.
26. Osmond DA, Inscho EW. P2X(1) receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo. Am J Physiol Renal Physiol 298: F1360-F1368, 2010.
27. Palmer BF. Disturbances in renal autoregulation and the susceptibility to hypertension-induced chronic kidney disease. Am J Med Sci 328: 330-343, 2004.
28. Quiroz Y, Pons H, Gordon KL, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, Johnson RJ, Rodriguez-Iturbe B. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 281: F38-F47, 2001.
29. Roson MI, Cao G, Della Penna S, Gorzalczany S, Pandolfo M, Toblli JE, Fernandez BE. Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure. Hypertens Res 31: 707-715, 2008.
30. Schiffrin EL. T lymphocytes: a role in hypertension? Curr Opin Nephrol Hypertens 19: 181-186, 2010.
31. Sharma K, Cook A, Smith M, Valancius C, Inscho EW. TGF-fj impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol 288: F1069-F1077, 2005.
32. Suthanthiran M, Gerber LM, Schwartz JE, Sharma VK, Medeiros M, Marion R, Pickering TG, August P. Circulating transforming growth factor-beta1 levels and the risk for kidney disease in African Americans. Kidney Int 76: 72-80, 2009.
33. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand 179: 217-223, 2003.
34. 2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension. Hypertension 46: 562-568, 2005.